COMMUNIQUÉ RÉGLEMENTÉ
News
-
Covivio - 2026 Half-year financial report
-
Covivio - Rapport financier semestriel 2026
-
Capital et droits de vote au 31 juillet 2026
-
Total number of voting rights and shares making up the share capital at July 31, 2026
-
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
-
Kleen Hy-Dro-Gen Inc. Is Pleased to Announce Dual ISO 9001:2015 and TSSA Certifications, Bolstering Operational Quality and Technical Safety Governance
-
Nextech3D.ai Provides Update on Acquisition of Remaining ARway Shares
-
Lockheed Martin and NioCorp Sign MOU
-
Moderna annonce le début d'un essai clinique de phase 1 portant sur l’ARNm-1469, son vaccin expérimental contre l'ébolavirus de Bundibugyo
-
ACCESS Newswire to Host Second Quarter Earnings Conference Call on August 11, 2026
-
Vonovia: Attractive Core Business Growth and Positive Valuation
-
Sandoz delivers strong H1 2026 results, with outstanding biosimilar growth in the second quarter
-
Strong H1 performance led by momentum in Research. 2026 outlook updated
-
Klöckner & Co continues solid operational performance in the second quarter of 2026 and moves forward with business combination with Worthington Steel
-
R&S Group provides trading update for H1 2026